CRLF2 and acute lymphoblastic leukemia: To identify a specific molecular signature for BCR-ABL1-like B-ALL, we examined a dataset from patients with B-other ALL (n = 49) by targeted RNA-Seq that, after clustering, grouped a subset of patients with overexpression of CRLF2 and mutations in several genes related to the BCR-ABL1-like signature.